Federal Register notice: FDA sends to OMB an information collection extension entitled Product Jurisdiction and Combination Products 21 CFR Parts 3 a...
UCB makes suggestions for FDA to consider in developing a framework to optimize post-approval pregnancy safety studies.
FDA clears GE Healthcares Critical Care Suite 2.1 that includes a pneumothorax algorithm.
FDA grants Arcturus Therapeutics an orphan drug designation for ARCT-032 and its use to treat cystic fibrosis.
Federal Register notices: FDA publishes notices about the regulatory review period determinations for eight drug products sponsored by KemPharm, Apell...
FDA accepts for review a Karuna Therapeutics NDA for KarXT (xanomeline-trospium) for treating schizophrenia in adults.
Stakeholders comment positively on an FDA draft guidance on developing products to prevent or treat graft-versus-host disease.
A CDER study examines generic nasal spray distribution factors that could speed the development of generic sprays.